Cathepsin S inhibitors
US8895497B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 6, 2010 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Oct 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Cathepsin S inhibitors having formula (I), (II), (III) or (IV) as shown in the specification. These inhibitors can be used to treat cancer and autoimmune/inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.